What is BVS's market cap?

$780.04M, based on the Nov 4 close of $11.42.

What is BVS's P/E ratio?

13.0× trailing-twelve-month earnings of $60.06M.

Does Bioventus pay a dividend?

No regular cash dividend has been paid in the last year.

How much of BVS is sold short?

3.2M shares, 6.9% of float, as of Oct 15, 2026.

What sector is BVS in?

Healthcare, in the Surgical Instruments industry.

NASDAQ · BVSHealthcareSurgical Instruments

Bioventus Inc. Class A Common Stock (BVS)

$11.42+4.34%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$11.42▲ 51.26% in range

Nov 4, 2025Low $6.53 · High $15.26Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Bioventus closed at $11.42 on Nov 4, up 4.34%, 25.2% below its 52-week closing high. Volume of 1.3M shares was 2.37× its 20-day average (well above normal).

Split-adjusted performance: -12.8% over one month, +4.6% over six months, +74.1% over one year.

In the quarter ended Sep 26, 2026, revenue was $142.44M, up 2.7% from a year earlier, with a net margin of 4.2%.

Short interest was 3.2M shares at the Oct 15 settlement (6.9% of float, 8.9 days to cover).

Market cap$780.0M68.3M shares

Revenue · quarter$142.4M+2.7% YoY

Diluted EPS$0.08+60.0% YoY

P/E · TTM13.0×P/S 1.3×

Net margin4.2%Gross 68.2%

Dividend yieldNone$0.61 last paid

52-week range6.53 – 15.26−25.2% from high

Volume1.3M2.37× 20-day avg

Volatility · 60d56.6%Annualised

Short % of float6.9%9.0 days to cover

Net cash-$199.1MCash $30.7M

Next earnings—Not scheduled

Split-adjusted performance

1W −22.0%1M −12.8%3M −18.3%6M +4.6%YTD +53.5%1Y +74.1%3Y +222.6%5Y −23.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum56

Revenue growth35

Net margin69

Value (low P/E)83

Size65

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →

Shares short3.2M+0.5% vs prior

Days to cover9.0Settled Oct 15

% of float6.9%

Short vol. 10d65.8%of daily volume

Closest peers by size in Surgical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
BVSBioventus	$11.42	+4.34%	+4.6%	+2.7%	4.2%	13.0	$780.0M
KIDSOrthoPediatrics	$33.51	+6.69%	+95.7%	+18.6%	−8.2%	—	$875.0M	Compare
BBNXBeta Bionics	$16.95	+12.25%	+60.4%	+30.3%	−68.6%	—	$921.5M	Compare
TCMDTactile Systems Technology	$27.18	+9.69%	+7.4%	+7.1%	7.8%	25.9	$615.7M	Compare
SIBNSI-BONE	$24.95	+4.96%	+92.1%	+15.2%	−7.3%	—	$1.12B	Compare
IRMDiRadimed	$88.58	+9.21%	+2.7%	+14.2%	26.9%	47.2	$1.13B	Compare
SGHTSight Sciences	$9.68	+2.76%	+125.1%	+19.5%	−19.0%	—	$533.3M	Compare
SGPSpyGlass Pharma	$34.45	0.00%	+37.5%	—	—	—	$1.15B	Compare
IARTIntegra LifeSciences	$14.82	+8.73%	+5.9%	+2.3%	3.6%	88.6	$1.15B	Compare

News about Bioventus

All news →

Bioventus (BVS) Matches Q3 Earnings EstimatesZacks Investment Research · 2d agoNeutral Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026GlobeNewswire Inc. · Oct 27, 2026Neutral Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare ConferenceGlobeNewswire Inc. · Jun 2, 2026▲ Positive

Quick answers

What does Bioventus do?: Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S.
What is BVS's market cap?: $780.04M, based on the Nov 4 close of $11.42.
What is BVS's P/E ratio?: 13.0× trailing-twelve-month earnings of $60.06M.
Does Bioventus pay a dividend?: No regular cash dividend has been paid in the last year.
How much of BVS is sold short?: 3.2M shares, 6.9% of float, as of Oct 15, 2026.
What sector is BVS in?: Healthcare, in the Surgical Instruments industry.

About Bioventus

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

HQ: Durham, NC950 employeesListed Feb 11, 2021bioventus.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology